nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—ovarian follicle—polycystic ovary syndrome	0.142	0.383	CbGeAlD
Nepafenac—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0581	0.113	CbGpPWpGaD
Nepafenac—Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.0502	0.447	CrCbGaD
Nepafenac—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0363	0.0703	CbGpPWpGaD
Nepafenac—Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.0275	0.245	CrCbGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0219	0.0424	CbGpPWpGaD
Nepafenac—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.0193	0.0374	CbGpPWpGaD
Nepafenac—PTGS2—embryo—polycystic ovary syndrome	0.0193	0.0518	CbGeAlD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0187	0.0362	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0174	0.0337	CbGpPWpGaD
Nepafenac—Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.016	0.142	CrCbGaD
Nepafenac—PTGS2—adrenal cortex—polycystic ovary syndrome	0.0158	0.0424	CbGeAlD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0148	0.0288	CbGpPWpGaD
Nepafenac—PTGS1—endometrium—polycystic ovary syndrome	0.0147	0.0396	CbGeAlD
Nepafenac—PTGS2—endometrium—polycystic ovary syndrome	0.0141	0.0379	CbGeAlD
Nepafenac—PTGS1—uterus—polycystic ovary syndrome	0.0136	0.0365	CbGeAlD
Nepafenac—PTGS1—pituitary gland—polycystic ovary syndrome	0.0133	0.0359	CbGeAlD
Nepafenac—PTGS1—adipose tissue—polycystic ovary syndrome	0.0133	0.0357	CbGeAlD
Nepafenac—PTGS2—uterus—polycystic ovary syndrome	0.013	0.0349	CbGeAlD
Nepafenac—PTGS2—pituitary gland—polycystic ovary syndrome	0.0127	0.0343	CbGeAlD
Nepafenac—PTGS2—adipose tissue—polycystic ovary syndrome	0.0127	0.0342	CbGeAlD
Nepafenac—PTGS1—adrenal gland—polycystic ovary syndrome	0.0119	0.0321	CbGeAlD
Nepafenac—PTGS2—adrenal gland—polycystic ovary syndrome	0.0114	0.0306	CbGeAlD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.0111	0.0215	CbGpPWpGaD
Nepafenac—PTGS1—female gonad—polycystic ovary syndrome	0.0111	0.0299	CbGeAlD
Nepafenac—PTGS1—vagina—polycystic ovary syndrome	0.011	0.0297	CbGeAlD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.0108	0.0208	CbGpPWpGaD
Nepafenac—PTGS2—female gonad—polycystic ovary syndrome	0.0106	0.0286	CbGeAlD
Nepafenac—PTGS2—vagina—polycystic ovary syndrome	0.0106	0.0284	CbGeAlD
Nepafenac—PTGS1—endocrine gland—polycystic ovary syndrome	0.0103	0.0278	CbGeAlD
Nepafenac—PTGS2—endocrine gland—polycystic ovary syndrome	0.00988	0.0266	CbGeAlD
Nepafenac—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00945	0.0183	CbGpPWpGaD
Nepafenac—Modafinil—ADRA1B—polycystic ovary syndrome	0.00881	0.0785	CrCbGaD
Nepafenac—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00866	0.0168	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00854	0.0165	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00815	0.0158	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00803	0.0156	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.0075	0.0145	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00675	0.0131	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.00663	0.0129	CbGpPWpGaD
Nepafenac—Mebendazole—CYP1A1—polycystic ovary syndrome	0.00659	0.0587	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00647	0.0125	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00637	0.0124	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.00616	0.0119	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00575	0.0112	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00536	0.0104	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00501	0.00971	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00466	0.00902	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00457	0.00885	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00452	0.00876	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00424	0.00821	CbGpPWpGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.00392	0.0076	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00389	0.00754	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00369	0.00715	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00368	0.00714	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.0036	0.00697	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00359	0.00695	CbGpPWpGaD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00342	0.00662	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00337	0.00652	CbGpPWpGaD
Nepafenac—Diclofenac—CYP1A1—polycystic ovary syndrome	0.00322	0.0287	CrCbGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.0031	0.00602	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00309	0.00599	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.003	0.00582	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00298	0.00577	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00297	0.00576	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00285	0.00552	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00282	0.00547	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00266	0.00516	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00258	0.005	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00254	0.00493	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00251	0.00487	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00247	0.00479	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00239	0.00464	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00236	0.00458	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00234	0.00454	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00226	0.00438	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00225	0.00437	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00225	0.00437	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00221	0.00429	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00215	0.00417	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00201	0.0039	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.002	0.00388	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.002	0.00387	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00196	0.00379	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.0019	0.00368	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00189	0.00366	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00184	0.00356	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00179	0.00347	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00179	0.00347	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00179	0.00347	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00179	0.00346	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00171	0.00331	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00169	0.00327	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00159	0.00308	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00158	0.00306	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.0015	0.0029	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00147	0.00285	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00146	0.00283	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00145	0.00281	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00142	0.00275	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.00139	0.0027	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00139	0.00269	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00139	0.00269	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00136	0.00263	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00132	0.00257	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.00132	0.00255	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00129	0.00251	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00127	0.00246	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.00127	0.00246	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00125	0.00243	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00118	0.00229	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00118	0.00229	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.00118	0.00228	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00115	0.00224	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00115	0.00223	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.0011	0.00213	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00108	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00105	0.00204	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00103	0.00199	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00102	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.00101	0.00195	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.00101	0.00195	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.001	0.00194	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.001	0.00194	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000995	0.00193	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000965	0.00187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00095	0.00184	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000937	0.00182	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000916	0.00177	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000874	0.00169	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000855	0.00166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000841	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000826	0.0016	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000811	0.00157	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000797	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000797	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000797	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000766	0.00148	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.00076	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000754	0.00146	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000752	0.00146	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000721	0.0014	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000694	0.00134	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000678	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000678	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000667	0.00129	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000647	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000642	0.00124	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000639	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000633	0.00123	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000606	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000604	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000597	0.00116	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.00059	0.00114	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000576	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000558	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000549	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00054	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000538	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000529	0.00103	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000514	0.000995	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000513	0.000995	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000507	0.000983	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000497	0.000964	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000491	0.000951	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000487	0.000944	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000481	0.000932	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.00048	0.000929	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000468	0.000907	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000461	0.000893	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000458	0.000888	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000457	0.000887	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000455	0.000882	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000452	0.000875	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000448	0.000869	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000443	0.000859	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000437	0.000846	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00043	0.000833	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000423	0.00082	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000408	0.00079	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000407	0.000789	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000401	0.000777	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000395	0.000765	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000381	0.000738	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000366	0.000709	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000366	0.000709	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000364	0.000705	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000361	0.0007	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000359	0.000695	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000356	0.00069	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000343	0.000665	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000341	0.000661	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000337	0.000654	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000336	0.000651	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000335	0.000649	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000322	0.000624	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000299	0.000579	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000291	0.000563	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000285	0.000552	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000283	0.000548	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.00027	0.000523	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.00027	0.000523	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000266	0.000515	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000265	0.000513	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000252	0.000487	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000238	0.000462	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000237	0.00046	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000227	0.00044	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000226	0.000438	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000214	0.000415	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000204	0.000395	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000201	0.00039	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.0002	0.000388	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.0002	0.000387	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000198	0.000384	CbGpPWpGaD
Nepafenac—PTGS2—Disease—INS—polycystic ovary syndrome	0.00019	0.000367	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000183	0.000355	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000174	0.000338	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	0.000162	0.000314	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—polycystic ovary syndrome	0.00016	0.000309	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INS—polycystic ovary syndrome	0.000159	0.000308	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—polycystic ovary syndrome	8.29e-05	0.000161	CbGpPWpGaD
